Cataract surgery under systemic anticoagulant therapy with coumarin

Area of Science:

• Ophthalmology
• Cardiology
• Pharmacology

Background:

• Systemic anticoagulants like coumarin are often used for cardiovascular conditions.
• Managing patients on anticoagulants undergoing surgery requires careful consideration of bleeding risks.
• Cataract surgery is a common procedure where anticoagulation management is crucial.

Purpose of the Study:

• To evaluate the clinical outcomes of cataract surgery in patients continuing systemic coumarin therapy.
• To compare complication rates between patients on coumarin and those not on anticoagulation.
• To determine if coumarin therapy necessitates discontinuation before standard cataract surgery.

Main Methods:

• A comparative nonrandomized study involving 441 patients undergoing phacoemulsification with topical anesthesia.
• A study group of 21 patients continued systemic coumarin therapy.
• A control group of 420 patients did not receive pre-operative coumarin therapy.

Main Results:

• No significant differences in intraoperative or postoperative hemorrhages were observed between groups.
• Rates of intraoperative complications, such as posterior capsule rupture, were similar.
• Postoperative visual acuity and intraocular pressure did not significantly differ between the coumarin and control groups.

Conclusions:

• Standard phacoemulsification with topical anesthesia can be performed safely in patients on systemic coumarin therapy.
• Continuing coumarin therapy does not appear to significantly increase surgical complication rates.
• Systemic coumarin therapy does not require discontinuation prior to cataract surgery.